Kymera Therapeutics Inc (KYMR) — Financial Flexibility Index
Kymera Therapeutics Inc (KYMR) has a Financial Flexibility Index of -0.68x as of March 2026. Free cash flow of $-88.41 Million (operating CF $-88.84 Million minus capex $434.00K) represents -1% of total liabilities ($129.38 Million). Check Kymera Therapeutics Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Kymera Therapeutics Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Kymera Therapeutics Inc across 8 annual periods. See Kymera Therapeutics Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Kymera Therapeutics Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Kymera Therapeutics Inc. For the full company profile including market capitalisation, see Kymera Therapeutics Inc market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.42x | $-231.44 Million | $-232.89 Million | $163.15 Million | ▼ -11.2% |
| 2024 | -1.28x | $-181.66 Million | $-194.50 Million | $142.42 Million | ▼ -237.4% |
| 2023 | -0.38x | $-68.35 Million | $-102.83 Million | $180.79 Million | ▲ +71.6% |
| 2022 | -1.33x | $-150.25 Million | $-153.09 Million | $112.98 Million | ▼ -52.7% |
| 2021 | -0.87x | $-127.35 Million | $-128.95 Million | $146.27 Million | ▼ -282.0% |
| 2020 | 0.48x | $97.23 Million | $88.13 Million | $203.29 Million | ▲ +395.7% |
| 2019 | 0.10x | $18.44 Million | $17.91 Million | $191.11 Million | ▲ +146.0% |
| 2018 | -0.21x | $-16.51 Million | $-17.86 Million | $78.67 Million | — |